Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
Katia Bruxvoort, Lina S. Sy, Lei Qian, et al.
BMJ (2021), pp. e068848-e068848
Open Access | Times Cited: 221

Showing 26-50 of 221 citing articles:

Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis
Ivan T. Lee, Raffael Nachbagauer, David J. Ensz, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 57
Safety and Immunogenicity of SARS-CoV-2 Spike Receptor-Binding Domain andN-Terminal Domain mRNA Vaccine
Spyros Chalkias, Antionette Pragalos, Adebayo Akinsola, et al.
The Journal of Infectious Diseases (2025)
Closed Access | Times Cited: 1
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung
Matthew Gagné, Kizzmekia S. Corbett, Barbara J. Flynn, et al.
Cell (2021) Vol. 185, Iss. 1, pp. 113-130.e15
Open Access | Times Cited: 73
Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review
Swarnali Das, Suvrendu Sankar Kar, Sovan Samanta, et al.
Immunologic Research (2022) Vol. 70, Iss. 3, pp. 289-315
Open Access | Times Cited: 64
The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 591-591
Open Access | Times Cited: 62
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern in real-world: a literature review and meta-analysis
Weihao Shao, Xiaorui Chen, Caifang Zheng, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2383-2392
Open Access | Times Cited: 62
Effectiveness of mRNA-1273 against SARS-CoV-2 omicron and delta variants
Hung Fu Tseng, Bradley K. Ackerson, Yi Luo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 57
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
Elsie Horne, William Hulme, Ruth H. Keogh, et al.
BMJ (2022), pp. e071249-e071249
Open Access | Times Cited: 54
Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants
Na Fan, Kepan Chen, Rong Zhu, et al.
Science Advances (2022) Vol. 8, Iss. 51
Open Access | Times Cited: 54
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron
Matthew Gagné, Juan I. Moliva, Kathryn E. Foulds, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 47
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Determinants of the Hesitancy toward COVID-19 Vaccination in Eastern European Countries and the Relationship with Health and Vaccine Literacy: A Literature Review
Alina Delia Popa, A. Enache, Iolanda Valentina Popa, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 672-672
Open Access | Times Cited: 46
Covid-19: virology, variants, and vaccines
Megan Young, Harry Crook, J. T. Scott, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000040-e000040
Open Access | Times Cited: 43
Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections
Salomé Desmecht, Aleksandr Tashkeev, Majdouline El Moussaoui, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
SARS-CoV-2: phenotype, genotype, and characterization of different variants
Mohammadreza Saberiyan, Elham Karimi, Zahra Khademi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40
Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape
Manojit Bhattacharya, Srijan Chatterjee, Ashish Ranjan Sharma, et al.
Folia Microbiologica (2022) Vol. 68, Iss. 1, pp. 17-28
Open Access | Times Cited: 38
A comparative overview of SARS‑CoV‑2 and its variants of concern
Aqeel Ahmad, Mirna Fawaz, Arafeen Aisha
Infezioni in Medicina (2022) Vol. 30, Iss. 3
Open Access | Times Cited: 37
Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy
Giacomo Grasselli, Alberto Zanella, Eleonora Carlesso, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2238871-e2238871
Open Access | Times Cited: 37
Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial
Christine A. Shaw, Runa Mithani, Archana Kapoor, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. e637-e646
Open Access | Times Cited: 9
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages
Bradley K. Ackerson, Katia Bruxvoort, Lei Qian, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 49
Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester
Ioana Mihaela Citu, Cosmin Cîtu, Florin Gorun, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 307-307
Open Access | Times Cited: 35
A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines
Xiao‐Feng He, Jiao Su, Yunan Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Association Between Vaccination Status and Mortality Among Intubated Patients With COVID-19–Related Acute Respiratory Distress Syndrome
Eirini Grapsa, Georgios Adamos, Ioannis Andrianopoulos, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2235219-e2235219
Open Access | Times Cited: 35

Scroll to top